Status:
NOT_YET_RECRUITING
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
Lead Sponsor:
Jian Li
Conditions:
M Protein
Monoclonal Gammopathy
Eligibility:
All Genders
18+ years
Brief Summary
iMS-LC Assay (intact M-protein Screening-Light Chain Assay) is a new technology based on mass spectrometry identification of intact clonal immunoglobulin light chains for the specific detection of M-p...
Eligibility Criteria
Inclusion
- Clinical patients:
- ≥18 years old;
- have concurrent SPEP + SIFE + FLC test results.
- Individuals undergoing routine physical examinations:
- ≥30 years old;
- have concurrent SPEP test results.
Exclusion
- NA
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
15600 Patients enrolled
Trial Details
Trial ID
NCT06489613
Start Date
July 1 2024
End Date
June 1 2025
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730